首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating
【24h】

Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating

机译:TCF4基因中的精神分裂症风险多态性与吸烟在听觉感觉门控的调节中相互作用

获取原文
获取原文并翻译 | 示例
       

摘要

Several polymorphisms of the transcription factor 4 (TCF4) have been shown to increase the risk for schizophrenia, particularly TCF4 rs9960767. This polymorphism is associated with impaired sensorimotor gating measured by prepulse inhibition—an established endophenotype of schizophrenia. We therefore investigated whether TCF4 polymorphisms also affect another proposed endophenotype of schizophrenia, namely sensory gating assessed by P50 suppression of the auditory evoked potential. Although sensorimotor gating and sensory gating are not identical, recent data suggest that they share genetic fundamentals. In a multicenter study at six academic institutions throughout Germany, we applied an auditory P50 suppression paradigm to 1,821 subjects (1,023 never-smokers, 798 smokers) randomly selected from the general population. Samples were genotyped for 21 TCF4 polymorphisms. Given that smoking is highly prevalent in schizophrenia and affects sensory gating, we also assessed smoking behavior, cotinine plasma concentrations, exhaled carbon monoxide, and the Fager-strom Test (FTND). P50 suppression was significantly decreased in carriers of schizophrenia risk alleles of the TCF4 polymorphisms rs9960767, rs10401120rs, rs17597926, and 17512836 (P < 0.0002-0.00005). These gene effects were modulated by smoking behavior as indicated by significant interactions of TCF4 genotype and smoking status; heavy smokers (FTND score >4) showed stronger gene effects on P50 suppression than light smokers and never-smokers. Our finding suggests that sensory gating is modulated by an interaction of TCF4 genotype with smoking, and both factors may play a role in early information processing deficits also in schizophrenia. Consequently, considering smoking behavior may facilitate the search for genetic risk factors for schizophrenia.
机译:转录因子4(TCF4)的几种多态性已显示会增加精神分裂症的风险,尤其是TCF4 rs9960767。这种多态性与通过脉冲前抑制(已确定的精神分裂症的内表型)测量的感觉运动门控受损有关。因此,我们调查了TCF4多态性是否也影响了精神分裂症的另一个拟议内表型,即通过P50抑制听觉诱发电位评估的感觉门控。尽管感觉运动门控和感觉门控并不相同,但最新数据表明它们具有遗传基础。在德国六个学术机构的一项多中心研究中,我们对从总人口中随机选择的1,821名受试者(1,023名从未吸烟者,798名烟民)应用了听觉P50抑制范例。对样品进行21 TCF4多态性基因分型。鉴于吸烟在精神分裂症中非常普遍并且影响感觉门控,我们还评估了吸烟行为,可替宁血浆浓度,呼出一氧化碳和Fager-strom检验(FTND)。在TCF4多态性rs9960767,rs10401120rs,rs17597926和17512836的精神分裂症风险等位基因携带者中,P50抑制显着降低(P <0.0002-0.00005)。这些基因效应受吸烟行为的调节,如TCF4基因型和吸烟状态的显着相互作用所表明。重度吸烟者(FTND分数> 4)显示出比轻度吸烟者和不吸烟者对P50抑制更强的基因作用。我们的发现表明,TCF4基因型与吸烟之间的相互作用会调节感觉门控,并且这两个因素也可能在精神分裂症的早期信息处理缺陷中起作用。因此,考虑吸烟行为可能有助于寻找精神分裂症的遗传危险因素。

著录项

  • 来源
  • 作者单位

    Experimental and Clinical Pharmacopsychology, Clinic for Affective Disorders and General Psychiatry, University Hospital of Psychiatry Zurich, 8032 Zurich,Switzerland,Department of Psychiatry and Psychotherapy, University of Bonn, 53105 Bonn, Germany;

    Department of Psychiatry, Heinrich-Heine University Dusseldorf, 40629 Dusseldorf, Germany,lnstitute of Neurosciences and Medicine, Helmholtz Research Center Juelich, 52428 Juelich, Germany;

    Department of Psychiatry, Heinrich-Heine University Dusseldorf, 40629 Dusseldorf, Germany,lnstitute of Neurosciences and Medicine, Helmholtz Research Center Juelich, 52428 Juelich, Germany,Department of Psychiatry, Johannes Gutenberg University Mainz, 55131 Mainz, Germany;

    Iinstitute of Medical Informatics and Statistics, Christian-Albrechts University Kiel, 24105 KieT, Germany;

    Department of Psychiatry, Heinrich-Heine University Dusseldorf, 40629 Dusseldorf, Germany;

    Department of Psychiatry and Psychotherapy, Rheinisch-Westfalische Technische Hochschule Aachen University,52062 Aachen, Germany;

    Experimental and Clinical Pharmacopsychology, Clinic for Affective Disorders and General Psychiatry, University Hospital of Psychiatry Zurich, 8032 Zurich,Switzerland;

    Department of Psychiatry and Psychotherapy, University of Bonn, 53105 Bonn, Germany;

    Department of Psychiatry and Psychotherapy, University of Bonn, 53105 Bonn, Germany;

    Department of Psychiatry and Psychotherapy, University of Bonn, 53105 Bonn, Germany;

    Department of Psychiatry and Psychotherapy, Rheinisch-Westfalische Technische Hochschule Aachen University,52062 Aachen, Germany;

    lnstitute of Medical Biometry, Informatics and Epidemiology, University of Bonn, 53105 Bonn, Germany;

    Department of Psychiatry, Johannes Gutenberg University Mainz, 55131 Mainz, Germany;

    Department of Psychiatry,Friedrich-Alexander- University Erlangen-Nuernberg, 91054 Erlangen, Germany;

    Department of Psychiatry,Friedrich-Alexander- University Erlangen-Nuernberg, 91054 Erlangen, Germany;

    Department of Addictive Behavior and Addictive Medicine, CentralInstitute of Mental Health, 68159 Mannheim, Germany;

    Department of Psychiatry, Charite University Hospital, Campus Mitte, 10117 Berlin, Germany;

    Experimental and Clinical Pharmacopsychology, Clinic for Affective Disorders and General Psychiatry, University Hospital of Psychiatry Zurich, 8032 Zurich,Switzerland;

    Department of Psychiatry and Psychotherapy, University of Bonn, 53105 Bonn, Germany,German Center for Neurodegenerative Diseases, 53105 Bonn, Germany;

    Department of Psychiatry, Charite University Hospital, Campus Mitte, 10117 Berlin, Germany;

    Cologne Center for Genomics, Cologne University, 50931 Cologne, Germany;

    Cologne Center for Genomics, Cologne University, 50931 Cologne, Germany;

    Cologne Center for Genomics, Cologne University, 50931 Cologne, Germany;

    Cologne Center for Genomics, Cologne University, 50931 Cologne, Germany;

    Department of Psychiatry and Psychotherapy, University of Bonn, 53105 Bonn, Germany,German Center for Neurodegenerative Diseases, 53105 Bonn, Germany;

    lnstitute of Neurosciences and Medicine, Helmholtz Research Center Juelich, 52428 Juelich, Germany,Cologne Center for Genomics, Cologne University, 50931 Cologne, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    single nucleotide polymorphism; intermediate phenotype; nicotine; gene-environment interaction;

    机译:单核苷酸多态性中间表型尼古丁;基因-环境相互作用;
  • 入库时间 2022-08-18 00:40:23

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号